Literature DB >> 28583916

Balancing Anticoagulation Decisions in Patients on Dialysis with Atrial Fibrillation.

Eli N Deal1, Jerrica E Shuster2.   

Abstract

Entities:  

Keywords:  anticoagulation; apixaban; atrial fibrillation; dialysis; rivaroxaban

Mesh：

Substances：

Year:  2017        PMID： 28583916      PMCID： PMC5491304          DOI： 10.1681/ASN.2017040451

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  15 in total

1.  Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  John J You; Daniel E Singer; Patricia A Howard; Deirdre A Lane; Mark H Eckman; Margaret C Fang; Elaine M Hylek; Sam Schulman; Alan S Go; Michael Hughes; Frederick A Spencer; Warren J Manning; Jonathan L Halperin; Gregory Y H Lip
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.

Authors:  Ron Pisters; Deirdre A Lane; Robby Nieuwlaat; Cees B de Vos; Harry J G M Crijns; Gregory Y H Lip
Journal:  Chest       Date:  2010-03-18       Impact factor: 9.410

3.  Pharmacokinetics, Pharmacodynamics, and Safety of Single-Dose Rivaroxaban in Chronic Hemodialysis.

Authors:  Clapton Dias; Kenneth Todd Moore; Joe Murphy; Jay Ariyawansa; William Smith; Roger M Mills; Matthew R Weir
Journal:  Am J Nephrol       Date:  2016-04-22       Impact factor: 3.754

4.  Oral apixaban for the treatment of acute venous thromboembolism.

Authors:  Giancarlo Agnelli; Harry R Buller; Alexander Cohen; Madelyn Curto; Alexander S Gallus; Margot Johnson; Urszula Masiukiewicz; Raphael Pak; John Thompson; Gary E Raskob; Jeffrey I Weitz
Journal:  N Engl J Med       Date:  2013-07-01       Impact factor: 91.245

5.  Apixaban versus warfarin in patients with atrial fibrillation.

Authors:  Christopher B Granger; John H Alexander; John J V McMurray; Renato D Lopes; Elaine M Hylek; Michael Hanna; Hussein R Al-Khalidi; Jack Ansell; Dan Atar; Alvaro Avezum; M Cecilia Bahit; Rafael Diaz; J Donald Easton; Justin A Ezekowitz; Greg Flaker; David Garcia; Margarida Geraldes; Bernard J Gersh; Sergey Golitsyn; Shinya Goto; Antonio G Hermosillo; Stefan H Hohnloser; John Horowitz; Puneet Mohan; Petr Jansky; Basil S Lewis; Jose Luis Lopez-Sendon; Prem Pais; Alexander Parkhomenko; Freek W A Verheugt; Jun Zhu; Lars Wallentin
Journal:  N Engl J Med       Date:  2011-08-27       Impact factor: 91.245

6.  Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.

Authors:  Anders Nissen Bonde; Gregory Y H Lip; Anne-Lise Kamper; Peter Riis Hansen; Morten Lamberts; Kristine Hommel; Morten Lock Hansen; Gunnar Hilmar Gislason; Christian Torp-Pedersen; Jonas Bjerring Olesen
Journal:  J Am Coll Cardiol       Date:  2014-12-16       Impact factor: 24.094

7.  Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end-stage renal disease on hemodialysis.

Authors:  Xiaoli Wang; Giridhar Tirucherai; Thomas C Marbury; Jessie Wang; Ming Chang; Donglu Zhang; Yan Song; Janice Pursley; Rebecca A Boyd; Charles Frost
Journal:  J Clin Pharmacol       Date:  2015-12-22       Impact factor: 3.126

Review 8.  The intersection of risk and benefit: is warfarin anticoagulation suitable for atrial fibrillation in patients on hemodialysis?

Authors:  Manish M Sood; Paul Komenda; Amy R Sood; Claudio Rigatto; Joe Bueti
Journal:  Chest       Date:  2009-10       Impact factor: 9.410

Review 9.  Nonvitamin K Anticoagulant Agents in Patients With Advanced Chronic Kidney Disease or on Dialysis With AF.

Authors:  Kevin E Chan; Robert P Giugliano; Manesh R Patel; Stuart Abramson; Meg Jardine; Sophia Zhao; Vlado Perkovic; Franklin W Maddux; Jonathan P Piccini
Journal:  J Am Coll Cardiol       Date:  2016-06-21       Impact factor: 24.094

10.  Efficacy and safety of warfarin in dialysis patients with atrial fibrillation: a systematic review and meta-analysis.

Authors:  Surapon Nochaiwong; Chidchanok Ruengorn; Rattanaporn Awiphan; Phongsak Dandecha; Kajohnsak Noppakun; Arintaya Phrommintikul
Journal:  Open Heart       Date:  2016-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.